Avidity Biosciences, Inc. short interest in 2021
In 2021, Avidity Biosciences, Inc.'s disclosed short interest ran from 8.46% of shares outstanding on 15 Jan 2021 to 8.43% on 31 Dec 2021, a change of -0.03 percentage points. The year's high was 17.52% on 14 May 2021 and its low 7.84% on 29 Jan 2021, averaging 13.47% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 50.34 days on 28 May 2021. Full history: Avidity Biosciences, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2021 in figures
- Start of year
- 8.46% (15 Jan 2021)
- End of year
- 8.43% (31 Dec 2021)
- Change
- -0.03 pp
- High
- 17.52% (14 May 2021)
- Low
- 7.84% (29 Jan 2021)
- Average
- 13.47%
- Highest days to cover
- 50.34 (28 May 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 8.46% | 19.02 | |
| 29 Jan 2021 | 7.84% | 11.57 | |
| 12 Feb 2021 | 8.51% | 15.03 | |
| 26 Feb 2021 | 9.72% | 7.06 | |
| 15 Mar 2021 | 11.87% | 12.16 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 15.49% | 11.52 | |
| 15 Apr 2021 | 16.96% | 21.10 | |
| 30 Apr 2021 | 17.32% | 34.36 | |
| 14 May 2021 | 17.52% | 30.57 | 10-Q filed, results (8-K) |
| 28 May 2021 | 17.44% | 50.34 | |
| 15 Jun 2021 | 17.02% | 34.59 | |
| 30 Jun 2021 | 16.29% | 17.76 | |
| 15 Jul 2021 | 16.12% | 35.09 | |
| 30 Jul 2021 | 16.10% | 31.34 | |
| 13 Aug 2021 | 16.70% | 13.46 | results (8-K), 10-Q filed, results (8-K) |
| 31 Aug 2021 | 17.30% | 26.11 | |
| 15 Sep 2021 | 14.42% | 7.02 | |
| 30 Sep 2021 | 14.97% | 13.79 | |
| 15 Oct 2021 | 13.93% | 27.64 | |
| 29 Oct 2021 | 11.34% | 37.91 | |
| 15 Nov 2021 | 10.37% | 29.49 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 10.02% | 15.40 | |
| 15 Dec 2021 | 9.08% | 13.82 | |
| 31 Dec 2021 | 8.43% | 17.59 |
See also: Avidity Biosciences, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.